Are you Dr. Shah?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 48 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
200 Medical 530 420 120 Plz
# 365
Los Angeles, CA 90095Phone+1 310-825-6301
Summary
- Dr. Neil Shah, MD is an oncologist in Los Angeles, California. He is currently licensed to practice medicine in California. He is affiliated with UCSF Medical Center and is an Assistant Professor at UCSF School of Medicine.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1998 - 2003
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1996 - 1998
- David Geffen School of Medicine at UCLAClass of 1996
Certifications & Licensure
- CA State Medical License 1998 - 2026
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Correction: Dose modification dynamics of ponatinib in patients with chronic-phase chronic myeloid leukemia (CP-CML) from the PACE and OPTIC trials.Elias Jabbour, Jane Apperley, Jorge Cortes, Delphine Rea, Michael Deininger
Leukemia. 2024-10-01 - 1 citationsAbsence of ABL1 exon 2-encoded SH3 residues in BCR::ABL1 destabilizes the autoinhibited kinase conformation and confers resistance to asciminib.Ariel Leyte-Vidal, RosaAnna DeFilippis, Ian R Outhwaite, Isabelle Kwan, Ji Young Lee
Leukemia. 2024-09-01 - 9 citationsBCR::ABL1 kinase N-lobe mutants confer moderate to high degrees of resistance to asciminib.Ariel Leyte-Vidal, Diego Garrido Ruiz, RosaAnna DeFilippis, Inga B Leske, Delphine Rea
Blood. 2024-08-08